Capital University of Medical Sciences, Beijing
Reports from Capital University of Medical Sciences, Beijing describe recent advances
Published in Healthcare Finance, Tax and Law Weekly, June 14th, 2006
This trend article about Capital University of Medical Sciences, Beijing is an immediate alert from LawRx to identify developing directions of research.
Study 1: Cilostazol therapy is an effective regimen for prevention of stent thrombosis and restenosis without the risk of increased bleeding.
Researchers in People's Republic Of China report, "Cilostazol is a newly developed antiplatelet drug that has been widely applied for clinical use. Its antiplatelet action appears to be mainly related to inhibition of intracellular phosphodiesterase...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- AFP Imaging Corp.
AFP Imaging reports 15% increase in sales - ALS Association
Group joins funding partnership for new hunt for amyotrophic lateral sclerosis genes - Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals added to NASDAQ Biotech Index - Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals reports 7% decrease in sales - Adams Respiratory Therapeutics, Inc.
Adams Respiratory Therapeutics added to NASDAQ Biotech Index - Adherex Technologies, Inc.
Adherex posts net loss of $0.08 per share - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
